Skip to Content

GSI 1 (Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)

Generic Name: cobicistat/elvitegravir/emtricitabine/tenofovir

Pill with imprint GSI 1 is Green, Capsule-shape and has been identified as Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg. It is supplied by Gilead Sciences, Inc..

Stribild is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 1

Stribild

Generic Name:
cobicistat/elvitegravir/emtricitabine/tenofovir
Imprint:
GSI 1
Strength:
cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-1201

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide